Clinical Trials Browser

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT01765231 2017-01-10

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

Phase 4 Unknown

190 enrolled

Lymphoid

Hepatitis B, Lymphoma

NCT01768195 2017-01-10

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy

Phase 4 Unknown

80 enrolled

Lymphoid

Hepatitis B, Lymphoma

NCT02779465 2016-05-20

VDHCC

Phase 4 Not yet recruiting

1,500 enrolled

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT00926757 2013-05-29

HBVNHL

Phase 4 Completed

80 enrolled

Lymphoid

Hepatitis B, Lymphoma, Lymphoma, Non-Hodgkin

NCT01102335 2010-04-13

TACEHBV

Phase 4 Unknown

80 enrolled

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00768157 2009-02-09

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Phase 4 Unknown

200 enrolled

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Recurrence

NCT00222664 2005-09-22

Qidong Hepatitis B Intervention Study

Phase 4 Completed

80,000 enrolled

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Clinical Trials

TRACER

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy

VDHCC

HBVNHL

TACEHBV

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Qidong Hepatitis B Intervention Study